9/12/2013

As many as 88% of the authors of clinical trial results failed to report conflicts of interest related to the trial sponsor or a competing drugmaker, but some authors over-disclosed, Danish researchers reported at the Peer Review Congress. The researchers reviewed 100 drug trials with one or more Danish authors, who are required to disclose paid collaboration with industry. Ambiguous guidelines from the International Committee of Medical Journal Editors may be causing confusion among researchers as to what constitutes a conflict of interest, the lead researcher said.

Related Summaries